Effect of Oral Probiotic Yeast on the Composition of the Vaginal

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT06124313` - A Single Group Study to Evaluate the Effects of a Vaginal Probiotic on Vaginal and Digestive Health	N/A
Completed	`NCT03543982` - Effects of Oral Probiotic Product on Vaginal Microbial Community and Parameters of Vaginal Health	N/A
Completed	`NCT00908570` - Topical Estriol for Vaginal Health	Phase 1
Active, not recruiting	`NCT05330091` - Garden of Life Once Daily Women's Probiotic: Vaginal pH and Quality of Life Study

See also

Status

Clinical Trial

Phase

Active, not recruiting

NCT06124313 - A Single Group Study to Evaluate the Effects of a Vaginal Probiotic on Vaginal and Digestive Health

N/A

Completed

NCT03543982 - Effects of Oral Probiotic Product on Vaginal Microbial Community and Parameters of Vaginal Health

N/A

Completed

NCT00908570 - Topical Estriol for Vaginal Health

Phase 1

Active, not recruiting

NCT05330091 - Garden of Life Once Daily Women's Probiotic: Vaginal pH and Quality of Life Study

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03574844
Study type	Interventional
Source	Lesaffre International
Contact
Status	Completed
Phase	N/A
Start date	March 1, 2018
Completion date	February 15, 2019

Effect of Oral Probiotic Yeast on the Composition of the Vaginal Microbiota in Healthy Women

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms